Beatrice Auletta

Beatrice Auletta

Auto-generated profile, based on publicly available information

Beatrice Auletta

Department of Industrial Engineering University of Padova Padova Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
LRLucia Rossi
Lucia Rossi
BABeatrice Auletta
Beatrice Auletta
LSLuigi Sartore
Luigi Sartore
MPMarco La Placa
Marco La Placa
GCGiada Cecconi
Giada Cecconi
Anna UrciuoloAnna Urciuolo
Anna Urciuolo
Skeletal muscle (SkM) tissue engineering aims to generate in vitro 3D products that can be implanted in patients to replace or repair damaged muscles. Having a humanized in vitro model able to mimic the interaction between the innervated recipient and the engineered SkMs at a functional level would greatly help in the evaluation of the graft potential. Here, a 3D in vitro model is developed that allows to investigation of the function, stability, and adaptability of the human neuromuscular (NM) system in response to an engineered SkM construct. To achieve this, decellularized SkMs (dSkM)‐based constructs are used as engineered SkM and human neuromuscular organoids (NMOs) as the recipient‐like NM system to create graft‐host SkM assembloids. We observed the migration of myogenic cells and invasion of neural axons from the NMO to the engineered SkM construct in the assembloids, with the generation of functional neuromuscular junctions (NMJs). Finally, assembloids are able to regenerate following acute damage, with SkM regeneration and functional recovery. Despite being limited by the absence of immunocompetent cells and vasculature, the data showed that the assembloid represents a useful tool to evaluate in vitro the response of the human innervated SkM to a potential tissue‐engineered SkM graft.

19 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BABeatrice Auletta
Beatrice Auletta
LRLucia Rossi
Lucia Rossi
FCFrancesca Cecchinato
Francesca Cecchinato
GBGilda Barbato
Gilda Barbato
ALAgnese Lauroja
Agnese Lauroja
Anna UrciuoloAnna Urciuolo
Anna Urciuolo
Human neuromuscular organoids (NMOs) derived from induced pluripotent stem cells (hiPSCs) hold a great potential to study (dys)functional human skeletal muscle (SkM) in vitro. The three-dimensional (3D) self-assembly of NMOs leads to the generation of spheroids, whose 3D organization cannot be controlled. Indeed, proper development, maturation and function of the innervated SkM require a well-defined multiscale 3D organization of the cells in a tissue-specific extracellular matrix (ECM) context. We hypothesized that extracellular structural imprinting along with hiPSC small-molecule-based differentiation could provide self-assembly guidance driving NMO morphogenesis and promoting the maturation and function of the human neuronal-coupled SkM in vitro models. We found that SkM ECM, provided as decellularized skeletal muscle, is able to reproducibly guide the morphogenesis of differentiating hiPSC toward multiscale structured tissue-like NMOs (t-NMOs). T-NMOs show contractile activity and possess functional neuromuscular junctions (NMJs), with mature neuromuscular system upon 30 days of hiPSC differentiation. We found that t-NMO could mimic altered muscle contraction upon administration of neurotoxins that act at NMJ level. Finally, we used hiPSCs derived from patients affected by Duchenne Muscular Dystrophy (DMD) to produce DMD t-NMOs that, upon neuronal stimulation, were able to mimic the altered SkM contractility and calcium dynamics typical of the disease. Altogether, our data confirm the ability of t-NMO platform to model in vitro human neuromuscular system (patho)physiology.

11 March 2026 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
PDF file
AHAgner Henrique Dorigo Hochuli
Agner Henrique Dorigo Hochuli
SDStefania D'AGostino
Stefania D'AGostino
LRLucia Rossi
Lucia Rossi
BABeatrice Auletta
Beatrice Auletta
LNLeonardo Nogara
Leonardo Nogara
Michela PozzobonMichela Pozzobon
Michela Pozzobon
Muscle defects caused by accidents, tumour resection and congenital malformations affect paediatric and adult patients. In this context, the neural‐muscle regeneration potential of mesenchymal stromal/stem cells derived from extracellular vesicles (EV) has been demonstrated by our group and others, but the mechanism by which EVs act remains unknown. This work aimed to investigate the neural‐muscle regeneration mechanism shown by EVs in vivo using three‐dimensional (3D) multicellular in vitro models. We used (1) human muscle decellularised tissue (ECM) engineered with human muscle precursor cells (hMPC) together with macrophages THP‐1 (M0) and (2) organotypic spinal cord from rat foetuses. We also studied neuroinflammation in 2D with primary microglia cells stimulated with lipopolysaccharide (LPS). Samples treated with good manufacturing practices (GMP)‐grade EVs were assessed, combining functional analyses, protein and gene expression. In the functional muscle model, EVs protect the cells from death after damage, decreasing cCAS3 and stimulating cell proliferation. The protein array and gene results highlighted that EVs act through the downregulation of the TNFα factor. In parallel, in both neuroinflammation‐induced microglia and organotypic spinal cord‐damaged models, EVs regulated the neuroinflammation by inhibiting TNFα and promoting neural axon sprouting. In summary, EVs guard great potential for tissue regeneration by TNFα modulation, promoting muscle‐neural regeneration.